Trial · NCT07901920
Platelets Rich Plasma Injection Versus Physiologic Saline Injection for Treatment of Myofascial Pain
NCT07901920, Not applicable, Recruiting, Cairo University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Platelets Rich Plasma Injection Versus Physiologic Saline Injection for Treatment of Myofascial Pain. Trials, record NCT07901920. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07901920
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Platelets Rich Plasma Injection Versus Physiologic Saline Injection for Treatment of Myofascial Pain
- NCT number
- NCT07901920
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 28 participants, estimated
- Lead sponsor
- Cairo University
- Conditions
- Platelets Rich Plasma, Saline, Myofascial Pain
- Interventions
- Platelet-rich plasma, Physiologic saline
- First posted
- 2026-10-28
- Last updated
- 2026-10-28
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Degree of pain | 24 weeks postoperatively | Pain level will be evaluated by using of Visual Analog Scale (VAS). VAS (0 represents "no pain" while 10 represents "the worst pain imaginable") |
| Secondary | Mean maximum unassisted mouth opening (MUMO) | 24 weeks postoperatively | Maximum distance between the incisal edges of the upper and lower central incisors during mouth opening will be measured in millimeters. Higher values indicate greater mouth opening. |
| Secondary | Mean maximum assisted mouth opening (MAMO) | 24 weeks postoperatively | Maximum distance between the incisal edges of the upper and lower central incisors during mouth opening will be measured in millimeters. Higher values indicate greater mouth opening. |
| Secondary | Range of right lateral excursive movements | 24 weeks postoperatively | Maximum voluntary lateral movement of the mandible to the right will be measured in millimeters as the displacement of the lower dental midline relative to the upper dental midline from the starting position. Higher values indicate greater lateral mandibular mobility. |
| Secondary | Range of left lateral excursive movements | 24 weeks postoperatively | Maximum voluntary lateral movement of the mandible to left will be measured in millimeters as the displacement of the lower dental midline relative to the upper dental midline from the starting position. Higher values indicate greater lateral mandibular mobility. |
| Secondary | Range of protrusive movement | 24 weeks postoperatively | Maximum voluntary forward movement of the mandible from the starting bite position will be measured in millimeters and accounting for the initial horizontal relationship between the upper and lower incisors (overjet). Higher values indicate greater protrusive mandibular mobility. |
| Secondary | Degree of patient satisfaction | 24 weeks postoperatively | Degree of patient satisfaction will be assessed on a 5-point Likert scale patient satisfaction (1, extremely dissatisfied; 2, unsatisfied; 3, neutral; 4, satisfied; 5, extremely satisfied). |
| Secondary | Range of mandibular motion | 24 weeks postoperatively | Range of mandibular motion will be assessed quantitatively with the help of digital vernier calipers (in millimeters). |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07901920
GET https://conductscience.org/api/trials/v1/NCT07901920/registered